时间多组学建模揭示慢性淋巴细胞白血病的B细胞受体增殖程序
该研究利用慢性淋巴细胞白血病细胞体外B细胞受体诱导增殖模型,在激活后1小时至4天采集108份时间序列转录组与蛋白质组图谱,识别出由13065个转录本和4027个蛋白构成的分层时间反应,并建立数学建模锁定14个早期基因驱动的转录网络,为淋巴恶性肿瘤提供潜在新靶点。
要点
- BCR激活后1小时至4天呈现结构化时间反应,含13065个转录本和4027个蛋白。
- 白血病增殖特征由430个基因和374个蛋白组成。
- 数学建模锁定14个早期基因,含EGR1/2、NF-kB及TANK、ROHF、KMO、IL4I1等新关联基因。
核心结论
- 研究揭示了原代白血病细胞中BCR激活后的增殖遗传程序,并识别出新的潜在治疗靶点。
研究设计与样本
- 利用慢性淋巴细胞白血病细胞的体外B细胞受体诱导增殖模型,在激活后1小时至4天生成108份时间序列转录组与蛋白质组图谱。
主要发现
- 时间序列数据揭示由13065个转录本和4027个蛋白构成的结构化时间反应。
- 该反应包含由430个基因和374个蛋白组成的白血病增殖特征。
- 数学建模突出一个由14个早期基因驱动的转录网络,其关联蛋白参与细胞增殖。
- 该网络包含预期基因EGR1/2和NF-kB,以及参与NF-kB信号调节的TANK、ROHF和免疫逃逸的KMO、IL4I1。
- KMO和IL4I1此前尚未与白血病细胞增殖相关联。
临床怎么用
- 该时间多组学联合建模方法可用于识别淋巴恶性肿瘤及依赖配体-受体相互作用的癌症的新兴治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
B-cell receptor (BCR) signaling is crucial for the pathophysiology of most mature B-cell lymphomas/leukemias and has emerged as a therapeutic target whose effectiveness remains limited by the occurrence of mutations. Therefore, deciphering the cellular program activated downstream this pathway has become of paramount importance for the development of innovative therapies. Using an original ex vivo model of BCR-induced proliferation of chronic lymphocytic leukemia cells, we generated 108 temporal transcriptional and proteomic profiles from 1 h up to 4 days after BCR activation. This dataset revealed a structured temporal response composed of 13,065 transcripts and 4027 proteins, comprising a leukemic proliferative signature consisting of 430 genes and 374 proteins. Mathematical modeling of this complex cellular response further highlighted a transcriptional network driven by 14 early genes linked to proteins involved in cell proliferation. This group includes expected genes (EGR1/2, NF-kB) and genes involved in NF-kB signaling modulation (TANK, ROHF) and immune evasion (KMO, IL4I1) that have not yet been associated with leukemic cells proliferation. Our study unveils the BCR-activated proliferative genetic program in primary leukemic cells. This approach combining temporal measurements with modeling allows identifying new putative targets for innovative therapy of lymphoid malignancies and also cancers dependent on ligand-receptor interactions.
引用
- Schleiss C, Carapito R, Fornecker LM, et al. Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia. Leukemia. 2021. PMID: 33833385. doi:10.1038/s41375-021-01221-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。